Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study.
Fiche publication
Date publication
janvier 2023
Journal
Pediatric nephrology (Berlin, Germany)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BAHRAM Siamak
Tous les auteurs :
Mahi SL, Bahram S, Harambat J, Allard L, Merlin E, Belot A, Ranchin B, Tenenbaum J, Magnavacca M, Haumesser L, Allain-Launay E, Pietrement C, Flodrops H, Ruin M, Dossier C, Decramer S, Ballot-Schmitt C, Boyer OG, Seugé L, Ulinski T, Zaloszyc A
Lien Pubmed
Résumé
Pediatric ANCA vasculitis is a rare group of diseases with a scarcity of data in children. Annual incidence appeared to increase in the last several years, placing higher interest in the clinical and therapeutical outcomes of the disorder. Also, the growing use of rituximab questions the latest outcomes in these diseases. We therefore conducted a retrospective study to better understand the current characteristics, management, and the latest outcomes of the disorder.
Mots clés
ANCA-associated vasculitis, Kidney outcome, Pediatric, Relapse
Référence
Pediatr Nephrol. 2023 01 9;: